cns.jpg (2811 bytes)



Journal Home
Editorial Board
Instructions for Contributors
Subscription Rates

© Neva Press, Inc. 2005

CNS Drug Reviews

Table of Contents

Volume 4, No. 3

201 E-5842:  A New Potent and Preferential Sigma Ligand.  Preclinical Pharmacological Profile
X. Guitart, X. Codony, M. Ballarin, A. Dordal and A. J. Farré
225 Preclinical and Pharmacological Studies of AG284, a Soluble HLA-DR2:Myelin Basic Protein Peptide Complex for the Treatment of Multiple Sclerosis
Edward G. Spack, Nancy G. Wehner and Jeffrey L. Winkelhake
247 Ipidacrine (NIK-247):  A Review of Multiple Mechanisms as an Antidementia Agent
Jun Kojima, Kenji Onodera, Mitsuo Ozeki and Kunio Nakayama
260 Vigabatrin
Raman Sankar and Aline T. Derdiarian
Meeting Reports
275 The 21st Annual Meeting of the Canadian College of Neuropsychopharmacology.  Montreal, Canada.   June 14-17, 1998.
L. K. Srivastava, J. Rochford and S. N. Young
287 XIIIth International Congress of Pharmacology.  New Drugs Affecting Central Nervous System.   Munich, Germany.  July 26-31, 1998.
A. Scriabine
291 Nucleotides and Their Receptors in the Nervous System.  Leipzig, Germany.  August 1-2, 1998.
Laszlo Köles
301 The 7th Biennial Meeting of the European Behavioral Pharmacology Society (EBPS '98), a Joint Meeting with the Behavioral Pharmacology Society.  Brno, Czech Republic.   September 2-6, 1998.
Alexandra E. Sulcova